0001209191-16-115635.txt : 20160426 0001209191-16-115635.hdr.sgml : 20160426 20160426120805 ACCESSION NUMBER: 0001209191-16-115635 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150204 FILED AS OF DATE: 20160426 DATE AS OF CHANGE: 20160426 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001337553 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 203109565 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7020 KIT CREEK ROAD STREET 2: SUITE 270 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: 919-313-9650 MAIL ADDRESS: STREET 1: 7020 KIT CREEK ROAD STREET 2: SUITE 270 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cagle Gerald D. CENTRAL INDEX KEY: 0001589991 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36152 FILM NUMBER: 161591048 MAIL ADDRESS: STREET 1: 135 U.S. HIGHWAY 206 STREET 2: SUITE 15 CITY: BEDMINSTER STATE: NJ ZIP: 07921 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-02-04 0 0001337553 AERIE PHARMACEUTICALS INC AERI 0001589991 Cagle Gerald D. C/O AERIE PHARMACEUTICALS, INC., 2030 MAIN STREET, SUITE 1500 IRVINE CA 92614 1 0 0 0 Common Stock 2015-02-04 4 P 0 500 25.60 A 4054 D Common Stock 2015-02-05 4 P 0 500 24.54 A 4554 D Common Stock 2015-08-10 4 P 0 100 16.31 A 4654 D Common Stock 2015-08-10 4 P 0 100 16.345 A 4754 D Common Stock 2015-08-10 4 P 0 100 16.35 A 4854 D Common Stock 2015-08-10 4 P 0 846 16.39 A 5700 D Common Stock 2015-08-12 4 P 0 500 15.4585 A 6200 D Common Stock 2015-08-28 4 P 0 1524 16.60 A 7724 D Common Stock 2015-08-28 4 P 0 476 16.5999 A 8200 D This Form 4 reports delinquent transactions that would have been reportable on February 6, 2015, August 12, 2015 and September 1, 2015. /s/ Richard J. Rubino, Attorney-in-Fact for Gerald D. Cagle 2016-04-26